Great West Life Assurance CO Passage Bio, Inc. Transaction History

Great West Life Assurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.63 - $3.46 $3,687 - $7,826	-2,262 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.66 - $6.49 $1,111 - $2,712	418 Added 22.67%	2,262 $8,000
Q4 2021 Feb 14, 2022	BUY	$6.24 - $10.2 $2,396 - $3,916	384 Added 26.3%	1,844 $11,000
Q2 2020 Aug 17, 2020	BUY	$14.59 - $36.07 $21,301 - $52,662	1,460 New	1,460 $40,000

33M

20.3K

500

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $54.5M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.